FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2167645928> ?p ?o ?g. }

• W2167645928 abstract "An actual clinical trial showed the effect of low dose radiotherapy in painful heel spur (plantar fasciitis) with single doses of 1.0 Gy and total doses of 6.0 Gy applied twice weekly. Furthermore, a lot of animal experimental and in vitro data reveals the effect of lower single doses of 0.5 Gy which may be superior in order to ease pain and reduce inflammation in patients with painful heel spur. Our goal is therefore to transfer this experimentally found effect into a randomized multicenter trial. This was a controlled, prospective, two-arm phase III-multicenter trial. The standard arm consisted of single fractions of 1.0 Gy applied two times a week, for a total dose of 6.0 Gy (total therapy time: 3 weeks). The experimental arm consisted of single fractions of 0.5 Gy applied 3 times a week, for a total dose of 6.0 Gy (total therapy time: 4 weeks). Following a statistical power calculation, there were 120 patients for each investigation arm. The main inclusion criteria were: age > = 40 years, clinical and radiologically diagnosed painful heel spur (plantar fasciitis), and current symptoms for at least 6 months. The main exclusion criteria were: former local trauma, surgery or radiotherapy of the heel; pregnant or breastfeeding women; and a pre-existing severe psychiatric or psychosomatic disorder. After approving a written informed consent the patients are randomized by a statistician into one of the trial arms. After radiotherapy, the patients are seen after six weeks, after twelve weeks and then every twelve weeks up to 48 weeks. Additionally, they receive a questionnaire every six weeks after the follow-up examinations up to 48 weeks. The effect is measured using the visual analogue scale of pain (VAS), the calcaneodynia score according to Rowe and the SF-12 score. The primary endpoint is the pain relief three months after therapy. Patients of both therapy arms with an insufficient result are offered a second radiotherapy series applying the standard dose (equally in both arms). This trial protocol has been approved by the expert panel of the DEGRO as well as by the Ethics committee of the Saarland Physicians’ chamber. Current trial registration at German Clinical Trials Register with the number DRKS00004458" @default.
• W2167645928 created "2016-06-24" @default.
• W2167645928 creator A5013323307 @default.
• W2167645928 creator A5019203166 @default.
• W2167645928 creator A5047469608 @default.
• W2167645928 creator A5081528577 @default.
• W2167645928 creator A5087433936 @default.
• W2167645928 date "2015-01-20" @default.
• W2167645928 modified "2023-09-26" @default.
• W2167645928 title "Randomized multicenter follow-up trial on the effect of radiotherapy for plantar fasciitis (painful heels spur) depending on dose and fractionation – a study protocol" @default.
• W2167645928 cites W125561502 @default.
• W2167645928 cites W1502234640 @default.
• W2167645928 cites W182724558 @default.
• W2167645928 cites W1975120963 @default.
• W2167645928 cites W1977800869 @default.
• W2167645928 cites W1981676280 @default.
• W2167645928 cites W1989704921 @default.
• W2167645928 cites W1991271939 @default.
• W2167645928 cites W1994357525 @default.
• W2167645928 cites W1995151203 @default.
• W2167645928 cites W1998593930 @default.
• W2167645928 cites W2005940617 @default.
• W2167645928 cites W2013477628 @default.
• W2167645928 cites W2013798549 @default.
• W2167645928 cites W201501558 @default.
• W2167645928 cites W2025719489 @default.
• W2167645928 cites W2087291502 @default.
• W2167645928 cites W2087419565 @default.
• W2167645928 cites W2127819726 @default.
• W2167645928 cites W2131613467 @default.
• W2167645928 cites W2136060364 @default.
• W2167645928 cites W2145302086 @default.
• W2167645928 cites W2151704682 @default.
• W2167645928 cites W2151996412 @default.
• W2167645928 cites W2152749441 @default.
• W2167645928 cites W2162715515 @default.
• W2167645928 cites W2165941703 @default.
• W2167645928 cites W2169573863 @default.
• W2167645928 cites W2170640007 @default.
• W2167645928 cites W2214710047 @default.
• W2167645928 cites W2403003605 @default.
• W2167645928 cites W2413611896 @default.
• W2167645928 cites W2414994225 @default.
• W2167645928 cites W2416033559 @default.
• W2167645928 cites W2416430149 @default.
• W2167645928 cites W2417460040 @default.
• W2167645928 cites W2417898810 @default.
• W2167645928 cites W2422845357 @default.
• W2167645928 cites W2463175758 @default.
• W2167645928 cites W3025301261 @default.
• W2167645928 cites W392052524 @default.
• W2167645928 cites W79448732 @default.
• W2167645928 cites W3024414420 @default.
• W2167645928 doi "https://doi.org/10.1186/s13014-015-0327-6" @default.
• W2167645928 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4349749" @default.
• W2167645928 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25601335" @default.
• W2167645928 hasPublicationYear "2015" @default.
• W2167645928 type Work @default.
• W2167645928 sameAs 2167645928 @default.
• W2167645928 citedByCount "6" @default.
• W2167645928 countsByYear W21676459282015 @default.
• W2167645928 countsByYear W21676459282017 @default.
• W2167645928 countsByYear W21676459282018 @default.
• W2167645928 countsByYear W21676459282022 @default.
• W2167645928 crossrefType "journal-article" @default.
• W2167645928 hasAuthorship W2167645928A5013323307 @default.
• W2167645928 hasAuthorship W2167645928A5019203166 @default.
• W2167645928 hasAuthorship W2167645928A5047469608 @default.
• W2167645928 hasAuthorship W2167645928A5081528577 @default.
• W2167645928 hasAuthorship W2167645928A5087433936 @default.
• W2167645928 hasBestOaLocation W21676459281 @default.
• W2167645928 hasConcept C105702510 @default.
• W2167645928 hasConcept C126322002 @default.
• W2167645928 hasConcept C141071460 @default.
• W2167645928 hasConcept C168563851 @default.
• W2167645928 hasConcept C204243189 @default.
• W2167645928 hasConcept C2777069013 @default.
• W2167645928 hasConcept C2777248721 @default.
• W2167645928 hasConcept C509974204 @default.
• W2167645928 hasConcept C535046627 @default.
• W2167645928 hasConcept C71924100 @default.
• W2167645928 hasConceptScore W2167645928C105702510 @default.
• W2167645928 hasConceptScore W2167645928C126322002 @default.
• W2167645928 hasConceptScore W2167645928C141071460 @default.
• W2167645928 hasConceptScore W2167645928C168563851 @default.
• W2167645928 hasConceptScore W2167645928C204243189 @default.
• W2167645928 hasConceptScore W2167645928C2777069013 @default.
• W2167645928 hasConceptScore W2167645928C2777248721 @default.
• W2167645928 hasConceptScore W2167645928C509974204 @default.
• W2167645928 hasConceptScore W2167645928C535046627 @default.
• W2167645928 hasConceptScore W2167645928C71924100 @default.
• W2167645928 hasIssue "1" @default.
• W2167645928 hasLocation W21676459281 @default.
• W2167645928 hasLocation W21676459282 @default.
• W2167645928 hasLocation W21676459283 @default.
• W2167645928 hasLocation W21676459284 @default.
• W2167645928 hasOpenAccess W2167645928 @default.
• W2167645928 hasPrimaryLocation W21676459281 @default.
• W2167645928 hasRelatedWork W1510511771 @default.
• W2167645928 hasRelatedWork W2017587608 @default.

• next